This inventor holds 2 USPTO granted patents. Top assignee: Japan Science and Technology Agency. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: Etsuko Ebisui: Innovator in Protein Crosslinking Inhibitors
Introduction
Etsuko Ebisui is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for protein crosslinking. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Ebisui's latest patents include an inhibitor of protein crosslinking and its applications. The first patent describes a ketone compound with transglutaminase-inhibiting activity, which is represented by specific chemical formulas. This compound is designed to prevent or treat diseases caused by protein crosslinking. The second patent provides a detailed description of various compounds that serve as protein cross-linking inhibitors, showcasing a range of chemical structures and their potential therapeutic uses.
Career Highlights
Etsuko Ebisui is affiliated with the Japan Science and Technology Agency, where he conducts research and development in innovative biochemistry. His work has garnered attention for its potential impact on treating diseases related to protein crosslinking.
Collaborations
Ebisui collaborates with esteemed colleagues, including Katsuhiko Mikoshiba and Akiko Terauchi, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their scientific investigations.
Conclusion
Etsuko Ebisui's contributions to the field of protein crosslinking inhibitors highlight his innovative spirit and dedication to advancing medical science. His patents represent a significant step forward in the development of therapeutic solutions for complex diseases.